Company Background

Dechra Veterinary Products EU (DVP-EU) is a business unit of Dechra Pharmaceuticals PLC. Located in Shrewsbury, England and in Uldum, Denmark it employs 212 people.

DVP-EU markets and sells pharmaceutical products, veterinary-exclusive pet diets, pet care products and instruments and consumables within 10 European countries and manages the relationship with our worldwide marketing partners.

The VetXX and Arnolds Veterinary Products brands and products are now incorporated into the Dechra Veterinary Products companion animal portfolio.

Dechra's strong product portfolio includes market leading products in dermatology, endocrinology, equine medicine, ophthalmology and critical care as well as a unique range of essential products including post patent veterinary licensed products, a pet care range and a portfolio of instruments and consumables. The recent addition of the veterinary-exclusive SPECIFIC® diet range for dogs and cats further strengthens the company's offering to the European veterinary market.

Through continued investment in the development of new products Dechra plans to enhance its product offering to veterinarians across Europe.

Dermatology

With the acquisition of the VetXX business Dechra has become a leading veterinary supplier in dermatological treatments.

• Canaural is now registered in 25 countries and it is the leading first line treatment for otitis externa in the dog and cat in the UK. It is complemented by our leading ear cleaning product CleanAural.
• Fuciderm is licensed for the treatment of surface pyoderma in the dog such as acute moist dermatitis and intertrigo. Fuciderm is sold in 23 countries worldwide.
• Malaseb is the only licensed medicated shampoo for cats and dogs in the UK. This product will be rolled out to other European territories during 2009.

Endocrinology

Endocrine disorders are a key focus for the business. The two leading brands are Vetoryl and Felimazole.

• Vetoryl is a novel product for the treatment of Cushing's syndrome. It is marketed within the EU in 21 territories and it is sold in the USA under an FDA waiver scheme and through special import schemes into other countries such as Canada and Australia.
• Felimazole was the first veterinary licensed treatment for feline hyperthyroidism.

Equine

We have 14 licensed products in the equine market. The leading product is Equipalazone which is the leading non-steroidal anti-inflammatory drug for the treatment of equine musculoskeletal disorders.

Ophthalmology

This is a highly specialised area of veterinary medicine where we have licensed pharmaceuticals as well as care products and instruments.

• Fucithalmic Vet is licensed for the treatment of conjunctivitis associated with Staphylococcal infections. It is currently licensed in 21 countries worldwide.

Critical Care

Dechra has a wide range of products that support emergency medicine including licensed pharmaceuticals, wound treatments, consumables and instruments.

• Vetivex is the leading brand in this range. This is a range of infusion fluids licensed for the treatment of dehydration.

Pet Diets

There are two main pet diet products which are sold exclusively through veterinary practices – SPECIFIC for dogs and SPECIFIC for cats. Each range offers tailored life-stage and therapeutic diets.

Care Products

The care range has two key products CleanAural and Neutrale. CleanAural is an ear cleaner for frequent use in cat and dog ears producing excess wax. Neutrale is a range of specialist shampoos for skin conditions in dogs.